Clinical trial
The Combination Use of Winlevi and Adapalene 0.3% Gel in Real Life Acne Treatment
NCT06336603 is registered in ClinicalTrials.gov with Sun Pharmaceutical Industries Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Combination Use of Winlevi and Adapalene 0.3% Gel in Real Life Acne Treatment
- Lead sponsor
- Sun Pharmaceutical Industries Limited
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 15, 2023
- Completion date
- October 29, 2024
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.